Analysis Supports Link Between Psoriasis and OSA Analysis Supports Link Between Psoriasis and OSA
Several hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 4, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Tapinarof Effective for AD in Patients as Young as 2 years Tapinarof Effective for AD in Patients as Young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.MDedge News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - November 29, 2023 Category: Pediatrics Tags: Dermatology News Source Type: news
Nail Psoriasis in Black Patients Often Overlooked Nail Psoriasis in Black Patients Often Overlooked
Underrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 28, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
A Pill for Psoriasis: The Latest Oral Medications A Pill for Psoriasis: The Latest Oral Medications
Kylee Wang and Dr Jennifer Soung give an overview of the current oral therapies for psoriasis, plus a look at potential new agents.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 28, 2023 Category: Dermatology Tags: Dermatology Commentary Source Type: news
New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis
(MedPage Today) -- Studies were presented at the American College of Rheumatology (ACR) annual meeting on the safety and efficacy of two oral tyrosine kinase 2 (TYK2) inhibitors -- TAK-279, a selective TYK2 inhibitor in patients with active psoriatic... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 22, 2023 Category: Dermatology Source Type: news
Pharma Brands Use AR Snapchat Lenses to Engage Consumers
Pharmaceutical companies Dermavant and Botox Cosmetic have turned to Snapchat to teach consumers about their products' FDA-approved use. To coincide with World Psoriasis Day on Oct. 29, Dermavant released a Snapchat Lens themed to its product Vtama that opens an augmented reality mini-game where…#botoxcosmetic #fda #worldpsoriasisday #dermavant #snapchatlens #vtama (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2023 Category: Consumer Health News Source Type: news
Which medicines, taken by mouth or injected, work best to treat a skin condition called plaque psoriasis?
Wednesday, November 15, 2023 (Source: Cochrane News and Events)
Source: Cochrane News and Events - November 15, 2023 Category: Information Technology Authors: Paolo Rosati Source Type: news
Why patients with this common skin condition should have their joint and heart health checked
Psoriasis is an autoimmune condition where the immune system attacks healthy skin cells, speeding up the rate at which they are renewed, causing crusty, red 'plaques' on the skin. (Source: the Mail online | Health)
Source: the Mail online | Health - November 13, 2023 Category: Consumer Health News Source Type: news
Palmoplantar Pustulosis: Treatment Challenges Palmoplantar Pustulosis: Treatment Challenges
When it comes to pustular disease localized to the hands and feet, treatment options have only modest efficacy, according to speakers at the annual National Psoriasis Foundation research symposium.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 13, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Teasing Apart Multiple Biologic Failure in Psoriasis, PsA Teasing Apart Multiple Biologic Failure in Psoriasis, PsA
' Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory? 'MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 8, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted
Sometimes even an apparently successful clinical trial may not be enough to save your drug—or your stock price—once you dig into the numbers. That’s what Ventyx Biosciences found when it reviewed data from a phase 2 trial of TYK2 inhibitor VTX958 in moderate to severe plaque psoriasis. The San…#tyk2 #sandiego #psoriasisarea #vtx958 #crohn #rajumohan #phd #s1p1r #vtx002 #nlrp3 (Source: Reuters: Health)
Source: Reuters: Health - November 8, 2023 Category: Consumer Health News Source Type: news
Psoriasis Remission: What to Expect
Psoriasis remission means your skin is clear and you no longer need to take medication. Learn the signs of psoriasis remission and how to get there. (Source: WebMD Health)
Source: WebMD Health - November 6, 2023 Category: Consumer Health News Source Type: news
My Tips for Dealing With Psoriasis
A woman who lives with moderate to severe psoriasis shares ways she manages her condition. (Source: WebMD Health)
Source: WebMD Health - November 6, 2023 Category: Consumer Health News Source Type: news
The Emotional Impact of Psoriasis
How one woman manages the emotional impact of moderate to severe psoriasis. (Source: WebMD Health)
Source: WebMD Health - November 6, 2023 Category: Consumer Health News Source Type: news
When Is a Biologic Right for Psoriasis?
When should you use a biologic for psoriasis treatment? Find out how biologic drugs treat psoriasis, and whether one might be right for you. (Source: WebMD Health)
Source: WebMD Health - November 3, 2023 Category: Consumer Health News Source Type: news
